ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO2 | Anoctamin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANXA1 | Annexin A1 | Cancer-related genes FDA approved drug targets Plasma proteins Transporters
| | | | | Expressed in all |
ANXA2 | Annexin A2 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
ANXA6 | Annexin A6 | Plasma proteins Transporters
| | | | | Expressed in all |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
BASP1 | Brain abundant, membrane attached signal protein 1 | Cytoskeleton related proteins Plasma proteins Transporters
| | | | | Tissue enhanced |
BAX | BCL2-associated X protein | Cancer-related genes Mitochondrial proteins Transporters
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Cancer-related genes Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CACNA1A | Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CAMP | Cathelicidin antimicrobial peptide | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CATSPER4 | Cation channel, sperm associated 4 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
CHRNA7 | Cholinergic receptor, nicotinic, alpha 7 (neuronal) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CLIC4 | Chloride intracellular channel 4 | Transporters
| | | | | Expressed in all |
CLNS1A | Chloride channel, nucleotide-sensitive, 1A | Cytoskeleton related proteins Transporters
| | | | | Expressed in all |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
FXYD5 | FXYD domain containing ion transport regulator 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GNLY | Granulysin | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HSPA1A | Heat shock 70kDa protein 1A | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
HSPA1B | Heat shock 70kDa protein 1B | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |